已收盘 09-06 16:00:00 美东时间
-0.035
-4.43%
PRINCETON, N.J., Aug. 28, 2024 /PRNewswire/ -- "The Future is BOAT" according t...
08-28 20:15
INVO Reports Record Second Quarter 2024 Financial Results With 481% Revenue Gro...
08-14 21:00
Second Quarter 2024 Highlights Net Income Attributable to Common Stockholders of $1.14 Per Diluted Share for Second Quarter 2024 Compared to $0.97 Per Diluted Share for Second Quarter 2023 F...
07-24 04:05
INVO Bioscience: On June 18, 2024, Co Received Notice From Nasdaq Informing Co ...
06-21 04:22
INVO Bioscience (NASDAQ:INVO) on Tuesday filed a prospectus for a mixed securities shelf offering of up to $100M. This prospectus is not an offer to sell these securities. SEC Filing More on INVO BioS...
05-22 04:52
Gainers: TSR (TSRI) +70% on being acquired by Vienna Parent for $13.40 per share. Pineapple Energy (PEGY) +64%. Crown ElectroKinetics (CRKN) +56%. Greenwave Technology Solutions (NASDAQ:GWAV) +56%. Ji...
05-16 21:25
INVO Bioscience (NASDAQ:INVO) reported quarterly losses of $(0.42) per share. The company reported $1.58 million in sales this quarter. This is a 352.84 percent increase over sales of $348.02 thousand the same period
05-16 04:45
INVO Bioscience's (NYSE:INVO) short percent of float has risen 39.13% since its...
05-16 04:15
Gainers Aclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during T...
04-26 00:31
Upadacitinib demonstrated superiority versus dupilumab in primary endpoint of simultaneous achievement of near complete skin clearance (EASI 90) and no to little itch (WP-NRS 0/1) at Week 16...
04-25 20:00